Get the Stockscreener App
14.31
0.00%
0.00
After Hours:
14.31
Gh Research Plc Stock (GHRS) Latest News
GHRS Stock Rallies 55% in a Week: Here's What You Should Know - MSN
Cantor Fitzgerald Forecasts GH Research FY2024 Earnings - Defense World
Small-Cap Stocks Surge: GH Research, Society Pass and Reborn Coffee Lead Monday Gainers - HPBL
GH Research (NASDAQ:GHRS) Earns Overweight Rating from Analysts at Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald sets GH Research stock Overweight, $14 target By Investing.com - Investing.com Australia
Cantor Fitzgerald sets GH Research stock Overweight, $14 target - MSN
GH Research initiated with an Overweight at Cantor Fitzgerald - TipRanks
Cantor Fitzgerald Initiates GH Research at Overweight -February 13, 2025 at 07:35 am EST - Marketscreener.com
GH Research - The Pharma Letter
These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week - newsbreak.com
GH Research (NASDAQ:GHRS) Shares Gap UpStill a Buy? - MarketBeat
GH Research PLC's (NASDAQ:GHRS) Top Key Executive Florian Schonharting is the most upbeat insider, and their holdings increased by 31% last week - Yahoo Finance
GH Research (NASDAQ:GHRS) Shares Gap DownHere's What Happened - MarketBeat
GH Research (NASDAQ:GHRS) Reaches New 12-Month HighWhat's Next? - MarketBeat
GH Research (NASDAQ:GHRS) Stock Price Down 7.6%Here's What Happened - MarketBeat
GH Research PLC (NASDAQ: GHRS) Up 56.77% From 52-Week Low; YTD Jumps 98.21% – Here’s What To Do Now - Marketing Sentinel
GH Research (NASDAQ:GHRS) Hits New 1-Year HighShould You Buy? - MarketBeat
GH Research PLC Raises $139.8 Million Through Share Offering - TipRanks
Taking on analysts’ expectations and winning: GH Research PLC (GHRS) - SETE News
Financial Metrics Unveiled: GH Research PLC (GHRS)’s Key Ratios in the Spotlight - The Dwinnex
Where are the Opportunities in (GHRS) - Stock Traders Daily
H.C. Wainwright maintains buy on GH Research stock, $40 target - MSN
GH Research PLC (GHRS) stock: A year of ups and downs - US Post News
GH Research Secures $150 Million in Public Offering - TipRanks
ForexTV | Small Business Resources - ForexTV.com
GH Research Prices Public Offering Of 10 Mln Shares At $15.00/shr - Nasdaq
Major Biotech Stock Offering: GH Research Secures $150M War Chest Through Share Sale - StockTitan
GH Research Announces Pricing of $150 Million Public Offering - Yahoo Finance
GH Research Announces Pricing of $150 Million Public Offering - GlobeNewswire Inc.
GH Research PLC [GHRS] is 157.00% higher this YTD. Is it still time to buy? - The DBT News
H.C. Wainwright maintains buy on GH Research stock, $40 target By Investing.com - Investing.com Australia
Why GH Research PLC (GHRS) Is Skyrocketing So Far In 2025 - MSN
GH Research launches $150 million offering - Green Market Report
Shares Soar as GH Research Unveils Promising Drug Trial - Value the Markets
GH Research Announces Proposed Public Offering - The Manila Times
Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025 - Insider Monkey
Healthcare's Hidden Gem: Why GH Research PLC Stock is Surging in 2025! - Jomfruland.net
GH Research stock target raised to $42 at Rodman & Renshaw - Investing.com India
GH Research Announces Primary Endpoint Met in Phase 2b - GlobeNewswire
GH Research stock target raised to $42 at Rodman & Renshaw By Investing.com - Investing.com South Africa
GH Research skyrockets on 5-MeO-DMT drug’s depression treatment breakthrough - Mugglehead
GH’s Phase IIb Data Show Potential Differentiation In Depression - Citeline News & Insights
GH Research Announces $150 Million Public Offering Of Ordinary Shares -February 03, 2025 at 05:22 pm EST - Marketscreener.com
0.81%
2.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):